Skip to content

A randomized clinic trial for the effect of warm acupuncture on primary dysmenorrhea and the pertinence with expectancy

A randomized clinic trial for the effect of warm acupuncture on primary dysmenorrhea and the pertinence with expectancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027256
Enrollment
Unknown
Registered
2019-11-06
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Menstrual period treatment group:Warm needle
Premenstrual treatment group:Warm needle

Sponsors

Southwestern Medical University Affiliated Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. 18-30 years old women (including 18 years old and 30 years old); 2. normal menstrual cycle in the past three months (28±7 days); 3. diagnosed according to the Clinical Guidelines for Primary Dysmenorrhea Primary dysmenorrhea; 4. according to the "Guidelines for Clinical Research of New Drugs in Traditional Chinese Medicine", the syndrome differentiation is cold and damp stagnation; 5. dysmenorrhea VAS (pain visual analogue scale) score is greater than 40mm; 6. agreed to participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. with history of childbirth or abortion; 2. combined with cardiovascular, hepatic, renal and hematopoietic Systematic and other life-threatening primary diseases as well as mental patients, gastric ulcer active period and asthma patients; 3. personnel who may not be completed, compliant or unsuitable for research by the researcher; 4. uncontrollable mental illness diagnosed; 5. Pregnancy intentions during the trial; 6. previous three weeks or receiving other treatment for primary dysmenorrhea; 7. taking drugs that affect the central nervous system, autonomic nerves and cardiovascular system such as atropine within 1 week before the test Stability, neostigmine, digitalis, propranolol, etc.; 8. acupuncture fear.

Design outcomes

Primary

MeasureTime frame
CMSS;VAS;Acupuncture expectation value evaluation scale;

Countries

China

Contacts

Public ContactWu Xiao

Southwestern Medical University Affiliated Chinese Medicine Hospital

29434230@qq.com+86 13880436122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026